HR 3789
DTC Act of 2025
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 13, 2026, 4:11 PM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Drug-price Transparency for Consumers Act of 2025 (DTC Act), aims to increase transparency in direct-to-consumer advertising for prescription drugs and biological products. It requires advertisements to include a clear disclosure of the wholesale acquisition cost (WAC) for a 30-day supply, helping consumers understand the potential cost of medications before seeking a prescription. The bill responds to concerns about the influence of advertising on drug prices and patient behavior, and seeks to empower consumers with more information.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Eleanor Holmes [D-DC-At Large] Norton
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.